Search PubMed⌕ Search

Biomedical subjects

B Müller

Publications and source records attributed to B Müller.

At least 451 records · Page 25Linked to original sources

Bronchoalveolar lavage proteins.

Since the discovery of the extra-cellular lining material of the lung and the possibility harvesting this source by endobronchial lavage this material has been the object of many studies directed to analyze its components, function and possible change in the diseased lung. The best known component of the extra-cellular lining material is the phospholipid and its fatty acid composition. But also on the cellular material much emphasis has been taken with the aim using its cytology as diagnostic parameter. However, very few informations were obtained about the protein material also washed out during the endobronchial lavage. As it was demonstrated by immunological methods the proteins of the extra-cellular lining material consist of serum identical proteins and those being obviously specific for the lung tissue. As found, most serum identical proteins occur in the same amounts as found in the blood serum, and the molecular weight in general range up to 160,000 daltons indicating that there must be a restriction in passage of high molecular weight proteins through the lumen walls of the endothelium. Some proteins, IgG, IgA, do occur in a higher level in the extra-cellular lining material leading to the suggestion that these proteins were synthesized and secreted by the lung tissue itself. The molecular weight of the lung specific proteins range from 16,000-340,000 daltons. Under reducing conditions however, for all species listed, two classes of subunits -36,000 and 12,000 daltons --result, indicating that these proteins might have comparable functions in the different species.(ABSTRACT TRUNCATED AT 250 WORDS)

Blood Proteins↗

Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

In a randomised, multicentre study intravenous IgG was compared with oral corticosteroids in 108 children with untreated acute immune thrombocytopenic purpura. IgG was an efficient treatment with no severe untoward reactions. The effects of corticosteroids and IgG were identical for rapid responders, who accounted for 62% of all patients. In contrast, patients requiring more than initial treatment responded better if randomised to IgG. The serum IgG level increased two-fold after IgG. A significant rise in IgM levels was observed after both IgG and corticosteroids. The platelet-associated IgG index was high in 75% of all patients. No significant differences between the two treatment groups were found, but rapid responders had a smaller mean initial platelet-associated IgG index which returned more rapidly and more permanently to normal than that of slow responders.

Acute Disease↗

Control of DNA polymerase alpha, beta and gamma activities in heat- and cold-sensitive mammalian cell-cycle mutants.

Two heat-sensitive (arrested in G1 at 39.5 degrees C) and two cold-sensitive (arrested in G1 at 33 degrees C) clonal cell-cycle mutants of the murine P-815-X2 mastocytoma line were tested for DNA polymerase alpha, beta and gamma activities. After transfer of mutant cells to the respective nonpermissive temperature, DNA polymerase alpha activities decreased more slowly than relative numbers of cells in S phase. Furthermore, numbers of DNA-synthesizing cells decreased to near-zero levels, whereas polymerase alpha activities in arrested cells were as high as 15-40% of control values. After return of arrested cells to the permissive temperature, polymerase alpha activities increased essentially in parallel with relative numbers of cells in S phase. In contrast to the changes in thymidine kinase (Schneider, E., Müller, B. and Schindler, R. (1983) Biochim. Biophys. Acta 741, 77-85), the decrease of polymerase alpha during entry of cells into proliferative quiescence thus appears to be under rather relaxed control, while after return of arrested cells to the permissive temperature the increase in polymerase alpha is tightly coupled with reentry of cells into S phase. For DNA polymerase beta and gamma activities, no obvious correlation with changes in the proliferative state of cells was detected.

Animals↗

Action of neurotensin on size, composition, and growth of pancreas and stomach in the rat.

Since the gastrointestinal peptide neurotensin has a stimulatory effect on the secretion of the exocrine pancreas and an inhibitory effect on secretion and motility of the stomach, we investigated whether chronic parenteral administration of neurotensin would affect pancreatic and gastric growth. We therefore infused synthetic neurotensin subcutaneously (dose, 43 and 282 pmol X kg-1 X min-1) in 20 Wistar rats for 2 weeks using Alzet osmotic minipumps and compared pancreatic weight, DNA, RNA, protein, lipase, amylase, pancreatic polypeptide and insulin with these parameters in 10 control rats from the same litter with subcutaneously implanted plastic cylinders approximately the size of the minipumps. In another experiment, synthetic neurotensin (836 pmol X kg-1) was injected intraperitoneally three times a day for 3 days in 12 rats. Thereafter, we measured pancreatic DNA and in vitro incorporation of [3H]thymidine into pancreatic DNA. These effects were compared with the actions of caerulein and normal saline. Long term infusion of the high neurotensin dose induced an increase of pancreatic weight (control: 0.87 g, neurotensin: 1.02 g) and of DNA (control: 2.5 micrograms; neurotensin: 3.5 micrograms) and pancreatic polypeptide (control: 2.4 ng; neurotensin: 7.4 ng) contents, whereas pancreatic protein, RNA, amylase and lipase contents were not stimulated. In relation to DNA, these parameters even were significantly depressed. Insulin remained unchanged. Intraperitoneal injection of neurotensin induced an increase of pancreatic DNA content and stimulated [3H]thymidine incorporation into DNA (control: 11 000 dpm/g; neurotensin: 15 800 dpm/g pancreas). Moreover, long-term neurotensin infusion with the high dose led to a rise in protein concentration and an increase in the thickness of the gastric antrum; antral DNA concentration was insignificantly stimulated. Parenteral neurotensin in the doses and at the times administered, led therefore, to hyperplasia of the pancreas and induced growth of the gastric antrum. It is concluded that neurotensin can act as a trophic factor on pancreas and gastric antrum of the rat. It remains to be determined whether this represents a physiological effect of neurotensin.

Aging↗

[The pharmacokinetics of ampicillin in pregnant women with H-gestosis in the last trimester of pregnancy].

In this paper pharmacokinetic data of ampicillin in 9 pregnant women with H-gestosis are compared with those from 8 healthy pregnant women in the last trimenon. 5 g Ampicillin were given as an i.v. bolus-injection. Ampicillin was determined in serum and urine by a polarographic method. Important kinetic data, such as concentration in serum, distribution into the peripheral compartment and t1/2 beta do not differ. The non-significantly changed central distribution volume (V1) as well as the reduced renal excretion in combination with normal serum creatinin values have to be considered in connection with the general constriction of blood vessels in pregnant women with H-gestosis. From the kinetic data one cannot derive any necessity for changing the mode of application or the dose of ampicillin in pregnant women with H-gestosis.

Ampicillin↗

Correlation between serum antibody-levels against group B streptococci and gestational age in newborns.

Sera from 33 newborn infants with gestational ages ranging from 27 to 41 weeks were tested by radioimmunoassay for IgG antibodies to surface antigens of group B streptococci (GBS) types Ia, Ib, II and III. Antibody levels to GBS antigens were positively correlated to gestational age and birthweight. However, only the correlations for anti-Ia and anti-II antibody levels reached statistical significance. Mean antibody concentrations in infants below 34 weeks of gestation were significantly lower for type Ia (P less than 0.001), type II (P less than 0.001) and type III (P = 0.05) than in infants above this limit. These findings might explain the higher rate of serious GBS-infections found among prematures as compared to full-term infants.

Antibodies, Bacterial↗

Intravenous administration of human IgG to newborn infants: changes in serum antibody levels to group B streptococci.

A human IgG preparation was given intravenously to 36 newborn infants admitted to the neonatal intensive care unit because of suspected septicaemia. IgG was given as a single dose of 0.4 g/kg body weight. Patient serum was obtained immediately before and 30 min after terminating the infusion. Blood was also withdrawn 2 days after giving the IgG in eight of the infants. The sera were tested by radioimmunoassay for IgG antibody levels to surface antigens of group B streptococci (GBS) types Ia, Ib, II and III and to R-protein. The mean increases in anti-type Ia, Ib, II, III and R-protein antibodies 30 min after the end of infusion were 81%, 73%, 49%, 60% and 69% of the preinfusion levels, respectively. This was followed by a rapid decrease during the following 2 days to 25%-32% of the initial increases. Based on the above findings, a controlled trial of passive immunisation in the management of neonatal GBS septicaemia seems justified. The rapid decline in antibody levels would necessitate a second infusion 24 h after the initial immunoglobulin administration if the suspicion of septicaemia persists.

Antibodies, Bacterial↗

Tracheal transplantation. III. Demonstration of transplantation antigens on the tracheal mucosa of inbred rat strains.

Tracheal transplants were performed on inbred strains of rats. Monoclonal antibodies were used in combination with the biotin-avidin technique for demonstrating donor-specific RT1 Ac transplantation antigen. Transplantation antigens were predominantly contained in the tracheal mucosal cells. No donor-specific antigens could be found in the mucosa of transplants which survived orthotopic tracheal transplantation for longer than 210 days. This suggests that the mucosa of the transplant is rejected and replaced by a mucosa from the recipient.

Animals↗

Identical serum proteins and specific bronchoalveolar lavage proteins in the adult human and the rat.

Whole unfractionated adult human and rat bronchoalveolar lavages were used for gradient electrophoresis, analytic isoelectric focusing, and immunoelectrophoretic studies, establishing a classification of identical serum proteins and specific lavage proteins. However, only with immunologic methods, using antiserum against bronchoalveolar lavage and serum from each species, were antigens identified that were also common to serum proteins, and to those that were specific for bronchoalveolar lavage. As a result, human bronchoalveolar lavage was classified into 21 identical serum antigens and 8 specific antigens, and for the rat the classification revealed 16 identical serum antigens, and 8 specific lavage antigens. A comparison of several well-established procedures for the preparation of bronchoalveolar lavage antigens showed that the ultrafiltration method produces the greatest number of specific antigens.

Animals↗

Human IgG antibodies to carbohydrate and protein antigens in mouse protection tests with group B streptococci.

The protective effect of four commercial human gammaglobulin batches (I-IV) in mice was studied using six different strains of group B streptococci (GBS): types Ia; Ib; II, R-protein negative (R-); II, R+; III, R-; and III, R+. Each mouse received 1.0 ml gammaglobulin and 0.5 ml bacteria, 10(6)-10(8) colony forming units (CFU). There was a close correlation between antibody levels measured by the use of radiolabeled protein A and the mouse-protective effect of the gamma-globulins. The mouse-protection tests demonstrated that batch I protected against GBS types Ia and III, R- at low concentration (65 mg/kg mouse weight), against type Ib at medium (260 mg/kg) and against type III, R+ at high concentration. Batch IV protected against types Ia and Ib, although the doses were four times higher than those in batch I, but did not protect against type III, R+. There was no mouse protection by any of the batches against type II. Antibody levels against Ibc and R, protein antigens, were substantially lower in batch IV. Because the results of these mouse-protection studies indicate the importance of such antibodies against protein antigens, batches I-III might be more useful for therapy of neonatal GBS-septicemia.

Animals↗

Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.

Iloprost (ILO) and ZK 96 480 (96 480) are stable prostacyclin (PGI2) analogues with platelet aggregation-inhibiting and hypotensive activities equal or superior to PGI2 which in contrast to PGI2 show longlasting pharmacological effects also after oral application. PGI2 as well as ILO and 96 480 with i.v. infusion at equihypotensive doses in rats after coronary artery ligation reduce ventricular ectopic beats, markedly reduce or abolish the periods of ventricular tachycardia and entirely prevent ventricular fibrilloflutter. Even nonhypotensive doses of the prostanoids attenuate postligation arrhythmias. Catecholamine depletion by reserpine pretreatment also markedly reduced the incidence of arrhythmias. As PGI2 and ILO have previously been shown by others to preserve noradrenaline content of sympathetic nerve terminals in ischemic myocardium, prevention of excessive catecholamine loss from hypoxically compromised sympathetic nerve terminals might be involved in the antiarrhythmic action of PGI2, ILO and 96 480.

Adenosine Diphosphate↗